Skip to main content

Vogt–Koyanagi–Harada Disease

  • Chapter
  • First Online:
Inflammatory and Infectious Ocular Disorders

Part of the book series: Retina Atlas ((RA))

Abstract

Vogt–Koyanagi–Harada (VKH) disease is an autoimmune disorder characterized by bilateral granulomatous panuveitis frequently associated with multiple extraocular findings such as vitiligo, poliosis, dysacusis, alopecia, and neurological involvement. In 1906, Vogt reported a patient with nontraumatic uveitis associated with poliosis. Bilateral idiopathic uveitis patients with poliosis, vitiligo, dysacousia, and alopecia were subsequently reported by Koyanagi in 1929. Because of the uniformity of these findings, disease reported by Vogt and Koyanagi was identified as one uveitis entity and named as Vogt–Koyanagi syndrome. In 1926, a disease characterized by cerebrospinal fluid (CSF) change and retinal detachment was reported by Harada as a separate uveitis entity. Subsequently, more and more studies suggested that Vogt–Koyanagi syndrome and Harada disease are the different manifestations in different stages of the same disease. In a study on 410 Chinese VKH patients, we revealed that Harada disease is the early manifestation, whereas Vogt–Koyanagi syndrome is the feature in recurrent stage (Yang et al. 2007).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Chi W, Yang P, Li B, Wu C, Jin H, Zhu X, et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol. 2007;119(5):1218–24. https://doi.org/10.1016/j.jaci.2007.01.010.

    Article  CAS  PubMed  Google Scholar 

  • Cuchacovich M, Solanes F, Diaz G, Cermenati T, Avila S, Verdaguer J, et al. Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2010;18(3):200–7. https://doi.org/10.3109/09273941003587541.

    Article  CAS  PubMed  Google Scholar 

  • Du L, Kijlstra A, Yang P. Vogt-Koyanagi-Harada disease: novel insights into pathophysiology, diagnosis and treatment. Prog Retin Eye Res. 2016;52:84–111. https://doi.org/10.1016/j.preteyeres.2016.02.002.

    Article  CAS  PubMed  Google Scholar 

  • Hayasaka S, Okabe H, Takahashi J. Systemic corticosteroid treatment in Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol. 1982;218(1):9–13.

    Article  CAS  Google Scholar 

  • Hou S, Du L, Lei B, Pang CP, Zhang M, Zhuang W, et al. Genome-wide association analysis of Vogt-Koyanagi-Harada syndrome identifies two new susceptibility loci at 1p31.2 and 10q21.3. Nat Genet. 2014;46(9):1007–11. https://doi.org/10.1038/ng.3061.

    Article  CAS  PubMed  Google Scholar 

  • Moorthy RS, Rajeev B, Smith RE, Rao NA. Incidence and management of cataracts in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1994;118(2):197–204.

    Article  CAS  Google Scholar 

  • Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39(4):265–92.

    Article  CAS  Google Scholar 

  • Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an International Committee on Nomenclature. Am J Ophthalmol. 2001;131(5):647–52.

    Article  CAS  Google Scholar 

  • Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol. 1991;109(5):682–7.

    Article  CAS  Google Scholar 

  • Sugita S, Takase H, Kawaguchi T, Taguchi C, Mochizuki M. Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007;27(2-3):87–95.

    Article  Google Scholar 

  • Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology. 2007;114(3):606–14. https://doi.org/10.1016/j.ophtha.2006.07.040.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yang, P., Ye, Z. (2020). Vogt–Koyanagi–Harada Disease. In: Yu, H. (eds) Inflammatory and Infectious Ocular Disorders. Retina Atlas. Springer, Singapore. https://doi.org/10.1007/978-981-13-8546-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-8546-9_9

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-8545-2

  • Online ISBN: 978-981-13-8546-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics